OXIWAVE NEPHRO 7%
IVFAB
Top

OXIWAVE NEPHRO 7%

MRP: 1,050

Packaging: 250ml

Pack Type: infusion

Composition:

L-Isoleucine USP 0.510g + L-Leucine USP 1.030g + L-Lysine Monoacetate USP Eq. to L-Lysine 0.710g + L-Methionine USP 0.280g + L-Phenylalanine USP 0.380g + L-Threonine USP 0.480g + L-Tryptophan USP 0.190g + L-Valise USP 0.620g + L-Arginine IP 0.490g + L-Histidine USP 0.430g + Glycine IP 0.320g + L-Alaninc USP 0.630g + L-Prolinc USP 0.430g + L-Serine USP 0.450g + Acetylcysteine USP Eq. to L-Cysteine 0.037g + L-Malic Acid IP 0.150g + Glacial Acetic Acid IP 0.138g + Water for Injections IP q.s. + Total Amino Acid 70.00 g/L + Total Nitrogen Content 10.80 g/L + Energy Content 287kcal/L + Osmolarity (talc.) 635 mOsmol/L

Indication:

Reload the Nutrition in CKD Patients

Description:

This intravenous amino acid solution is a balanced mixture of essential and non-essential amino acids designed to provide nutritional support for patients requiring parenteral nutrition. It contains key amino acids including L-Isoleucine, L-Leucine, L-Lysine, L-Methionine, L-Phenylalanine, L-Threonine, L-Tryptophan, L-Valine, L-Arginine, L-Histidine, Glycine, L-Alanine, L-Proline, L-Serine, and Acetylcysteine (source of L-Cysteine).

The solution also includes L-Malic Acid and Glacial Acetic Acid to help maintain physiological pH and osmolarity, with water for injections as the solvent. The formulation provides 70 g of total amino acids per liter with 10.8 g of nitrogen content and 287 kcal of energy per liter, supporting protein synthesis, tissue repair, and metabolic functions in patients who cannot meet their nutritional needs orally or enterally.

Tags:

Parenteral Nutrition Amino Acid Solutions Intravenous Nutrition Clinical Nutrition Essential Amino Acids
  • Provides balanced essential and non-essential amino acids
  • Supports protein synthesis and tissue repair
  • Suitable for patients needing complete parenteral nutrition
  • Maintains nitrogen balance and metabolic function
  • Osmolarity optimized for safe intravenous administration

Usage Information

Dosage

Dosage individualized based on patient weight, clinical condition, and nutritional needs Administer via central or peripheral IV line as prescribed Monitor metabolic parameters and adjust accordingly

Side Effects

Allergic reactions (rare) Electrolyte imbalance if improperly dosed Overload may cause metabolic acidosis or azotemia Local irritation at infusion site

Contraindications

Known hypersensitivity to any amino acid components Severe liver or kidney dysfunction without careful monitoring Metabolic disorders requiring amino acid restriction Use only under strict medical supervision

OXIWAVE NEPHRO 7% - IVFAB | Intralife Pharmaceuticals | Intralife